Argireline (Argireline (Acetyl Hexapeptide-3))
A synthetic hexapeptide that mimics SNAP-25 protein. Often called "topical Botox," it reduces expression lines by inhibiting neurotransmitter release at neuromuscular junctions.
How it works
Competes with SNAP-25 for position in SNARE complex, partially inhibiting vesicle docking and neurotransmitter release, reducing muscle contraction intensity.
Key facts
- Molecular weight: 889 Da
- Half-life: 8-12 hours (topical)
- Bioavailability: Moderate (topical)
- Storage: Room temperature, protected from heat.
Dosing overview
- Typical dose: 5-10% solution
- Frequency: 2x daily
- Duration: 4-8 weeks for initial results
- Route: Topical
Reported benefits
- Reduces expression wrinkles up to 30%
- Non-invasive Botox alternative
- Prevents new wrinkle formation
- No muscle paralysis
- Stackable with other peptides
Possible side effects
- Mild tingling
- Rare skin sensitivity
Research
- Efficacy of acetyl hexapeptide-8 on facial wrinkles (2021): 10% argireline reduced wrinkle depth around eyes by 30% after 30 days of twice-daily application.
- SNARE complex modulation by hexapeptide-8 (2019): Inhibited catecholamine release by 40% in chromaffin cells by competing with SNAP-25.
Compare Argireline
Community discussions about Argireline
- Thoughts on SNAP-25 vs Argireline for expression lines? - 4 comments
- Adding SNAP-8 to my routine for skin texture? - 4 comments
- Trying a 5% Argireline serum – any tips on layering it with other actives? - 2 comments
- Acetyl Hexapeptide-8 for expression wrinkles, is the hype real or just cosmetic wishful thinking? - 4 comments
- Trying Leuphasyl topically for fine lines – any experience? - 4 comments
- Ask the community about Argireline
Research and educational reference only. Not medical advice.